In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia. These genetic discoveries raise the promise of developing urgently needed new treatments targeting the underlying biology and pathophysiology of schizophrenia, according to a special article in the Journal of Clinical Psychopharmacology. The journal is published in the Lippincott portfolio by Wolters Kluwer.
- Study shows how our brains remain active during familiar, repetitive tasks
- Predation by Caspian terns on young steelhead means fewer return as adults
- Transparent, reflective objects now within grasp of robots
- Space to grow, or grow in space — how vertical farms could be ready to take-off
- Molecularly thin interface between polymers — for efficient CO2 capture membrane